PRTN3 and rheumatoid arthritis: These results not only challenge the conventional view that ACPA– RA is simply a seronegative variant of ACPA+ RA, but also highlight the potential for multi-omic profiling to refine RA classification and improve diagnostic and therapeutic strategies.